Top Markets
#1 Nesa Nesa +801.92%
#2 Cortex Cortex +68.10%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.20%
#4 Pons Pons +26.22%
#5 QuantixAI QuantixAI +23.95%
#6 EXOD EXOD +22.78%
#7 Instadapp Instadapp +18.46%
#8 Movement Movement +12.71%
#9 Magma Finance Magma Finance +11.78%
#10 SkyAI SkyAI +11.58%
Coin of the day
Nesa Nesa
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
SOL S.p.A. SOL S.p.A.

SOL S.p.A.

SOL
Classifica tra le azioni #3308
SOL S.p.A., a global enterprise established in Monza, Italy, in 1927, operates... SOL S.p.A., a global enterprise established in Monza, Italy, in 1927, operates as a subsidiary of Gas and Technologies World BV. The company primarily focuses on the research, manufacturing, and distribution of a diverse array of technical and medical gases, while simultaneously delivering comprehensive home healthcare solutions and associated medical equipment. Its extensive gas portfolio includes vital elements such as oxygen, nitrogen, and argon, alongside specialized gas mixtures, high-purity gases for the electronics industry, and food-grade gases. These products are supplied to various sectors including chemical, electronics, steel, metal, and food processing, as well as supporting environmental protection, scientific research, and healthcare. In the realm of home healthcare, SOL provides critical in-home therapies like oxygen, mechanical ventilation, and aerosol treatments. It also specializes in the diagnosis and management of respiratory sleep disorders, offers artificial nutrition programs, insulin pump therapy, immunotherapy, and dedicated support for pain and Parkinson's disease. Further extending its healthcare reach, the company delivers general home health and social care services, augmented by telemedicine platforms, digital health tools, and a range of healthcare aids. Beyond these core gas and home healthcare operations, SOL S.p.A. engages in a variety of complementary ventures. These encompass the design, construction, and management of biobanks; the generation and sale of hydroelectric power; and the provision of pre- and post-natal diagnostic screening. The company also develops and markets diagnostic systems and products for research and clinical applications across hospital, environmental, veterinary, and food sectors, alongside specialized bioshipping services for the secure transfer, storage, and handling of biological samples. Additional services include professional training, electromedical equipment support, hospital hygiene, environmental monitoring, and ambulance management, all facilitated by its proprietary InfoHealth SOLution web platform for operational oversight.
Prezzo delle azioni
$62.39
Ultima sincronizzazione: 2026-08-25
Capitalizzazione di mercato
$5.66B
Variazione (1 giorno)
-0.19%
Variazione (1 anno)
4.46%
Paese
IT
Scambia SOL S.p.A. (SOL)

Categoria

Basic Materials
Rapporto P/E per SOL S.p.A. (SOL)
Rapporto P/E al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di SOL S.p.A., il rapporto P/E attuale (TTM) è 0. Alla fine del 2026, il rapporto P/E era 0.
Storico del rapporto P/E per SOL S.p.A. da 2026 a 2026
Rapporto P/E alla fine di ogni anno
Anno Rapporto P/E Cambia
Non abbastanza dati per le date fornite.
Rapporto P/E per aziende simili o concorrenti
Azienda P/E Ratio Differenza del P/E Ratio Il paese
Linde plc Linde plc
Linde plc
LIN.US
 31.02 -
GB
L'Air Liquide S.A. L'Air Liquide S.A.
L'Air Liquide S.A.
AI.PA
 - -
FR
The Sherwin-Williams Company The Sherwin-Williams Company
The Sherwin-Williams Company
SHW.US
 32.79 -
US
Ecolab Inc. Ecolab Inc.
Ecolab Inc.
ECL.US
 36.81 -
US
Air Products and Chemicals, Inc. Air Products and Chemicals, Inc.
Air Products and Chemicals, Inc.
APD.US
 -1.49K -
US
Come leggere un P/E ratio?

Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.

Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.

Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.